health technology assessment
No description yet: the sentence for this tag has not been written. 7 records carry it: 7 people. Also written “health-technology-assessment”; the spellings share this page.
7 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Beth Devine President (2026-2027) · ISPOR (The Professional Society for Health Economics and Outcomes Research) Pharmacist-health economist serving as 2026-2027 President of ISPOR, the global society for health economics and outcomes research. | none | none | leadership, health economics | ||
Jean Lessi Director General · Haute Autorité de Santé Director General of the Haute Autorité de Santé, responsible for the agency's operations since January 2024. | none | none | leadership, regulation | ||
Lionel Collet President of the Collège · Haute Autorité de Santé Physician and former university president who chairs the Haute Autorité de Santé, France's health technology assessment and quality body. | none | none | leadership, regulation | ||
Robert Peel Chair of the Scottish Medicines Consortium · Scottish Medicines Consortium Kidney specialist from NHS Highland who chairs the Scottish Medicines Consortium, the body that decides which newly licensed medicines are accepted for use in the Scottish health service. | none | none | leadership, clinician-scientist, drug-reimbursement | ||
Robyn Ward Chair of the Pharmaceutical Benefits Advisory Committee · Pharmaceutical Benefits Advisory Committee Medical oncologist and cancer geneticist who chairs the independent expert committee that recommends which medicines Australia subsidises through the Pharmaceutical Benefits Scheme. | none | none | leadership, clinician-scientist, drug-reimbursement | ||
Sonja Optendrenk Impartial Chair (Unparteiische Vorsitzende), Gemeinsamer Bundesausschuss · Gemeinsamer Bundesausschuss / IQWiG Impartial chair of Germany's Federal Joint Committee (G-BA), the body that decides which treatments statutory health insurance covers. | none | none | leadership, regulation | ||
Thomas Kaiser Director (Institutsleiter), IQWiG · Gemeinsamer Bundesausschuss / IQWiG Physician who directs IQWiG, the German institute that produces the benefit assessments underpinning cancer drug pricing and coverage decisions. | none | none | leadership, regulation |
